Companies

See how salaries can vary from company to company

Brailsford & Dunlavey provides market research, financial analysis, architectural programming & site evaluation services. view company details

Center for Global Development is a nonprofit research organization, works to reduce global poverty and inequality. view company details

Course5i is a provider of market research, brand measurement, customer retention and social media analytics solutions for businesses. view company details

Digital Infuzion is an Information Technology firm that offers computer services, informatics and enterprise solutions to research centers. view company details

e.Republic is a publishing, research, event and new media company focused on state and local government and education. view company details

NWREL provides research and development assistance to education, government, community agencies and businesses. view company details

Hennepin Healthcare operates as a research center and philanthropic foundation that provides psychiatric program and home care services. view company details

InSites is a market research company that offers surveying, brand development and market performance testing services for businesses. view company details

LakePharma is a contract research organization that specializes in antibody and protein engineering, cell line development and protein production. view company details

Mindstream Interactive is a digital marketing agency that offers research, analytics and content creation services. view company details

Mondo is a staffing agency that offers executive research and staff augmentation services for IT and digital marketing companies. view company details

Ottawa University is a bilingual public research university that offers online, undergraduate, graduate and adult education programs. view company details

Parexel provides contract research, consulting, medical communications and related technology solutions for the biotechnology industry. view company details

The Children's Inn at the National Institutes of Health is a biomedical research center offer treatment for children's illnesses. view company details

Trial Runners is a provider of clinical research management services for biotechnology and pharmaceutical companies. view company details

University Of Nebraska is an educational and research institution that provides academic programs in the field of arts and science. view company details

YCharts is a fintech platform that provides investment research, stock screener and analytics solutions for investors. view company details

Epizyme, Inc., a late-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases primarily in the United States. The company's lead products candidate is tazemetostat, an inhibitor of the EZH2 histone methyltransferase, which is in the Phase II clinical trial for patients with relapsed or refractory non-hodgkin lymphoma (NHL); Phase II clinical trial for relapsed or refractory patients with mesothelioma characterized by BAP1 loss-of-function; and Phase II clinical trial for adults and Phase I clinical trial fo... view company details

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. The company is developing Zygel, a transdermal cannabidiol gel, which is in Phase II clinical trial for treating children and adolescent patients with developmental and epileptic encephalopathies; is in Phase II/III clinical trial to treat children and adolescent patients with fragile X syndrome; and is in Phase II clinical trial for treating children and adolescent pa... view company details

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Its lead drug candidate is Selinexor(KPT-330), which is in Phase IIb clinical study in treatments of refractory multiple myeloma; Phase Ib/II clinical study in combination with backbone treatments for multiple myeloma patients; Phase III clinical trial in combination with Velcade (bortezomib) and dexamethasone for multiple myeloma patients; Phase IIb cli... view company details